2cureX: Strengthened management to facilitate IndiTreat commercialization

Redeye endorses 2cureX appointing two new VPs to strengthen their commercial operations. Both Pia van der Zee, new VP of Marketing, and Jesper Floyd Kristiansen, new VP of Business Development Europe, have highly relevant backgrounds in the in vitro diagnostics industry. Considering the ongoing commercial IndiTreat launch, we believe their recruitments are timely and appropriate. Redeye projects their onboarding to facilitate IndiTreat distributor network expansion and IndiTreat commercial success in Europe. Simultaneously, 2cureX announced that current CBO Maarten van der Linden will leave the company at the end of June.

CB

Christian Binder

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.